Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery

Journal of Cardiac Surgery

Volumn 21, Issue 5, 2006, Pages 458-464

  Cagli, Kerim ^a,b   Ozeke, Ozcan ^a   Ergun, Kumral ^a   Budak, Baran ^a   Demirtas, Ertan ^a   Birincioglu, Cemal Levent ^a   Pac, Mustafa ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Kírkkonaklar Mah ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; METOPROLOL SUCCINATE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RISK FACTOR; RISK REDUCTION; TORSADE DES POINTES; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 33748292996     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2006.00277.x     Document Type: Article

References (40)

1. DiDomenico RJ, Massad MG: Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg 2005;79:728-740.
2. Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-1073.
3. Fuster V, Ryden LE, Asinger RW, et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-1923.
4. Cagli K, Gol MK, Keles T, et al: Risk factors associated with development of atrial fibrillation early after coronary artery bypass grafting. Am J Cardiol 2000;85:1259-1261.
5. Kalus JS, White CM, Caron MF, et al: Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg 2004;77:1288-1292.
6. Crosby LH, Pifalo WB, Woll KR, et al: Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990;66:1520-1522.
7. Mathew JP, Parks R, Savino JS, et al: Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. Multi Center Study of Perioperative Ischemia Research Group. JAMA 1996;276:300-306.
8. Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996;94:390-397.
9. Frost L, Molgaard H, Christiansen EH, et al: Atrial fibrillation and flutter after coronary artery bypass surgery: Epidemiology, risk factors and preventive trials. Int J Cardiol 1992;36:253-261.
10. Creswell LL, Schuessler RB, Rosenbloom M, et al: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-549.
11. Mathew JP, Fontes ML, Tudor IC, et al: A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-1729.
12. Weber UK, Osswald S, Huber M, et al: Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 1998;19:794-800.
13. Daoud EG, Strickberger SA, Man KC, et al: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-1791.
14. Katariya K, DeMarchena E, Bolooki H: Oral amiodarone reduces incidence of postoperative atrial fibrillation. Ann Thorac Surg 1999;68:1599-1603; discussion 1603-1604.
15. Giri S, White CM, Dunn AB, et al: Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): A randomised placebo-controlled trial. Lancet 2001;357:830-836.
16. Mostow ND, Vrobel TR, Noon D, et al: Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. Am Heart J 1990;120(6 Pt 1):1356-1363.
17. Guarnieri T, Nolan S, Gottlieb SO, et al: Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 1999;34:343-347.
18. Levine JH, Massumi A, Scheinman MM, et al: Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996;27:67-75.
19. Tokmakoglu H, Kandemir O, Gunaydin S, et al: Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. Eur J Cardiothorac Surg 2002;21:401-405.
20. Yagdi T, Nalbantgil S, Ayik F, et al: Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1420-1425.
21. Gosselink AT, Crijns HJ, Van Gelder IC, et al: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992;267:3289-3293.
22. Lee SH, Chang CM, Lu MJ, et al: Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2000;70:157-161.
23. Naccarelli GV, Rinkenberger RL, Dougherty AH, et al: Amiodarone: Pharmacology and antiarrhythmic and adverse effects. Pharmacotherapy 1985;5:298-313.
24. Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60:1709-1715.
25. Kaplan M, Kut MS, Icer UA, et al: Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003;125:344-352.
26. England MR, Gordon G, Salem M, et al: Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992;268:2395-2402.
27. Karmy-Jones R, Hamilton A, Dzavik V, et al: Magnesium sulfate prophylaxis after cardiac operations. Ann Thorac Surg 1995;59:502-507.
28. Fanning WJ, Thomas CS Jr, Roach A, et al: Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 1991;52:529-533.
29. Parikka H, Toivonen L, Pellinen T, et al: The influence of intravenous magnesium sulphate on the occurence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J 1993;14:251-258.
30. Toraman F, Karabulut EH, Alhan HC, et al: Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001;72:1256-1261.
31. Aglio LS, Stanford GG, Maddi R, et al: Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 1991;5:201-208.
32. Wilkes NJ, Mallett SV, Peachey T, et al: Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 2002;95:828-834.
33. Manners JM, Nielsen MS: Magnesium flux during open heart surgery. The effect of St Thomas' Hospital cardioplegia solution. Anaesthesia 1981;36:157-166.
34. 4 replacement. J Card Surg 1996;11:421-427.
35. Alghamdi AA, Al-Radi OO, Latter DA: Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: A systematic review and meta-analysis. J Card Surg 2005;20;293-299.
36. Kohno H, Koyanagi T, Kasegawa H, et al: Threeday magnesium administration prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2005;79:117-126.
37. Miller S, Crystal E, Garfinkle M, et al: Effects of magnesium on atrial fibrillation after cardiac surgery: A meta-analysis. Heart 2005;91:618-623.
38. Atar D, Serebruany V, Poulton J, et al: Effects of magnesium supplementation in a porcine model of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1994;24:603-611.
39. Yang Q, Liu YC, Zou W, et al: Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg 2002;124:361-370.
40. Chakraborti S, Chakraborti T, Mandal M, et al: Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 2002;238:163-179.